This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Asthma or COPD
and you are
over 60
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This is a randomized, multi-center, active-controlled, repeated measures design study in male and female patients 60 years of age and older with persistent asthma or COPD. Study will be conducted in 4 Italian University/Hospital Centers: Ferrara, Parma, Cassano delle Murge (Ba), Tradate. The primary efficacy parameter of the study is inhaler device usability (expressed as total number of repeated attempts required to achieve optimal use).

Provided treatments

  • Device: Spiromax (budesonide/formoterol)
  • Device: Turbohaler (budesonide/formoterol)
  • Device: Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate)
Tris trial is registered with FDA with number: NCT02757209. The sponsor of the trial is Consorzio Futuro in Ricerca and it is looking for 84 volunteers for the current phase.
Official trial title:
STUDY NUMBER: PMC-101-APT Usability and Adherence of Spiromax® Inhaler Device, Turbohaler® and Diskus® Inhaler Devices for Fixed Combination of Corticosteroid/Long-acting beta2- Agonist, in Adults With Asthma or COPD